TRIC-TB | Boosting Ethionamide efficacy and lowering the dose with a small molecule transcriptional modulators, to overcoming MDR-TB infections and define a new place for Ethionamide in 1st-line TB treatments.
01-05-2019
-29-02-2024
Show more information
Organisation
BioVersys SAS